Previous Article | Next Article 
Applied and Environmental Microbiology, October 1999, p. 4329-4333, Vol. 65, No. 10
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Outer Membrane of Gram-Negative Bacteria
Inhibits Antibacterial Activity of Brochocin-C
Yan
Gao,
Marco J.
van Belkum, and
Michael E.
Stiles*
Department of Agricultural, Food and
Nutritional Science, University of Alberta, Edmonton, Alberta, Canada
T6G 2P5
Received 15 March 1999/Accepted 21 July 1999
 |
ABSTRACT |
Brochocin-C is a two-peptide bacteriocin produced by
Brochothrix campestris ATCC 43754 that has a broad activity
spectrum comparable to that of nisin. Brochocin-C has an inhibitory
effect on EDTA-treated gram-negative bacteria, Salmonella
enterica serovar Typhimurium lipopolysaccharide mutants, and
spheroplasts of Typhimurium strains LT2 and SL3600. Brochocin-C
treatment of cells and spheroplasts of strains of LT2 and SL3600
resulted in hydrolysis of ATP. The outer membrane of gram-negative
bacteria protects the cytoplasmic membrane from the action of
brochocin-C. It appears that brochocin-C is similar to nisin and
possibly does not require a membrane receptor for its function;
however, the difference in effect of the two bacteriocins on
intracellular ATP indicates that they cause different pore sizes in the
cytoplasmic membrane.
 |
INTRODUCTION |
Brochocin-C produced by
Brochothrix campestris ATCC 43754 is a class IIb
(two-peptide) bacteriocin that was originally reported by Siragusa and
Cutter (22) and characterized by McCormick et al.
(15). Brochocin-C has a broad activity spectrum comparable to that of nisin, and it is active against a broad range of
gram-positive bacteria and spores of Clostridium and
Bacillus spp. (11, 15). Nisin A is a
well-characterized class I (lantibiotic) bacteriocin produced by
Lactococcus lactis subsp. lactis. It has been
widely accepted as a food preservative (6). Pediocin PA-1
produced by Pediococcus acidilactici PAC-1.0 is the most
extensively studied class IIa bacteriocin (8).
Mechanistic studies of several lantibiotics and nonlantibiotics have
revealed that their action occurs at the cytoplasmic membrane (7,
13, 19, 25). Nisin is not active against gram-negative bacteria,
but liposomes of gram-negative bacteria (7) and sublethally
heat-shocked gram-negative bacteria are inhibited by nisin A (5,
12). The outer membrane acts as a barrier to the action of nisin
on the cytoplasmic membrane. Gram-negative bacteria treated with
Tris-EDTA (24) and lipopolysaccharide (LPS) mutants of
Salmonella enterica serovar Typhimurium (23) are
sensitive to nisin A. Sublethally injured gram-negative bacteria are
also susceptible to treatment with pediocin PA-1/AcH (12).
The object of this study was to determine whether the antibacterial
activity of brochocin-C is comparable to that of nisin against
gram-negative bacteria by determining if the outer membrane acts as a
barrier to brochocin-C and by determining the effect of brochocin-C on
the release of ATP from cells and spheroplasts of gram-negative bacteria.
 |
MATERIALS AND METHODS |
Bacterial strains and growth media.
Carnobacterium
divergens NCFB 2855 (National Collection of Food Bacteria,
Reading, United Kingdom; LV13), B. campestris ATCC 43754, and P. acidilactici PAC-1.0 (8) were grown in APT
broth (All-Purpose Tween; Difco Laboratories, Detroit, Mich.) at
25°C. The gram-negative bacteria used in EDTA tests and Typhimurium LPS mutants were grown in brain heart infusion broth (Difco) at 37°C,
except for Typhimurium strains LT2 and SL3600, which were grown in
nutrient broth (Difco) and in proteose peptone-beef extract medium
(18) for spheroplast preparation, respectively. All of the
Salmonella LPS mutants were obtained from the
Salmonella Genetic Stock Centre (University of Calgary,
Calgary, Canada).
Partial purification of bacteriocins.
Brochocin-C was
partially purified (15) on Amberlite XAD-8 (BDH, Darmstadt,
Germany), and the 60% ethanol eluent was concentrated to yield 25,600 arbitrary activity units (AU) of brochocin-C per ml. Pediocin PA-1/AcH
was partially purified (10) by concentrating the 0.1%
trifluoroacetic acid eluent from Sephadex G-50 chromatography (Pharmacia, Uppsala, Sweden) to yield 102,400 AU/ml. Purified nisin
(Aplin and Barrett Ltd., Dorset, United Kingdom) was dissolved in 0.02 N HCl at 1 and 10 mg/ml, and stock solutions were stored at
70°C.
All of the bacteriocin solutions were filter sterilized (Millex-GV
filter; Millipore Corp., Bedford, Mass.). Activity (in AU per
milliliter) was calculated as the reciprocal of greatest dilution that
showed a clear zone of inhibition on a lawn of C. divergens
LV13 by a spot-on-lawn assay (4).
Effect of brochocin-C on EDTA-treated gram-negative
bacteria.
Activity of the three bacteriocins was tested against
strains of Escherichia coli and Salmonella spp.
in the presence of 20 mM EDTA, as described by Stevens et al.
(24). All of the bacteriocins were used at 3,200 AU/ml (for
nisin, this was equivalent to 250 µg/ml). Viable bacterial counts of
treated cells were determined before and after 30 min of treatment at
37°C. All experiments were repeated at least three times.
Effect of brochocin-C on Typhimurium LPS mutants.
Typhimurium LT2 and its LPS mutants (Table
1) were grown at 37°C to an optical
density at 600 nm of 0.15. The sensitivity of these strains to the
bacteriocins was tested by a spot-on-lawn assay with brochocin-C at
800, 1,600, 3,200, 6,400, and 12,800 AU/ml, with nisin at 1,280, 12,800, and 64,000 AU/ml (0.1, 1, and 5 mg/ml, respectively), and with
pediocin PA-1 at 204,800 AU/ml.
Effect of brochocin-C on spheroplasts of Typhimurium.
Typhimurium LT2 and SL3600 (1% inoculum) were grown aerobically at
37°C. When the absorbance of LT2 at 600 nm reached 0.4, the culture
was centrifuged at 3,000 × g and washed once and
resuspended in sterile 10 mM Tris-HCl at pH 8.0. LT2 spheroplasts were
prepared as described by Sambrook et al. (20), except that
the lysozyme and EDTA concentrations were 8 mg/ml and 0.05 M,
respectively. Spheroplasts were harvested after 15 min of incubation at
37°C. SL3600 spheroplasts were prepared as described by Osborn et al. (17). Spheroplasts were harvested by centrifugation at
3000 × g for 20 min and suspended in osmotically
protected buffer (21). Formation of spheroplasts was
monitored by phase-contrast microscopy. For use in experiments,
spheroplasts were diluted to an absorbance at 600 nm of 0.5 to 0.6. The
bacteriocins were added separately to a final concentration of 800 AU/ml. Suspensions with similar amounts of water were used as controls.
Absorbance at 260 and 600 nm was monitored at selected time intervals
during incubation at room temperature (23°C). To measure absorbance
at 260 nm, samples were centrifuged at 3,000 × g for
20 min.
ATP leakage from bacteriocin-treated cells and spheroplasts.
LT2 and SL3600 spheroplasts were suspended in osmotically protected
buffer. Cells of LT2 and SL3600 were grown aerobically to an absorbance
at 600 nm of 0.7. The cells from 50 ml of broth were harvested, washed
once with 50 mM potassium phosphate buffer (pH 7.8), and resuspended in
2 ml of the same buffer. Cells and spheroplasts were stored on ice.
Incubation mixtures consisting of 0.2 ml of cells or spheroplasts, 2.8 ml of 50 mM potassium phosphate buffer (pH 7.8), or osmotically
protected buffer containing 0.5% glucose were held at room
temperature. The bacteriocins were added to give final concentrations
of 800 AU/ml. The protonophore CCCP (carbonyl cyanide
m-chlorophenylhydrazone; Sigma Chemical Co., St. Louis, Mo.)
was used at 40 µM as a control. Samples were taken at selected time
intervals to determine ATP by bioluminescence assay (ATP
bioluminescence assay kit; Sigma). The amount of bioluminescence emitted was integrated for 10 s and recorded in relative light units (luminometer model 1250; LKB Wallac, Bromma, Sweden).
Extracellular ATP was determined in 100 µl of supernatant of samples
centrifuged at 3000 × g for 20 min.
 |
RESULTS |
Inhibition of gram-negative bacteria.
None of 29 strains of
gram-negative bacteria was sensitive to brochocin-C, nisin, or pediocin
PA-1. Treatment of E. coli ATCC 25922 and Salmonella
enterica serovar Choleraesuis ATCC 10708 with EDTA and
bacteriocins resulted in greater than a 2-log reduction in viable count
in the presence of brochocin-C or nisin, but there was no reduction in
the presence of pediocin PA-1 (Table 2). Viable counts of E. coli and serovar Choleraesuis treated
with nisin and EDTA decreased by 4 and 2.1 logs, respectively, compared with 6.6- and 4.2-log reductions reported by Stevens et al.
(24) for the same strains, even though a higher
concentration of nisin was used in our experiments.
Inhibition of Typhimurium LPS mutants.
Brochocin-C was
inhibitory to only two of the three strains of Typhimurium mutants with
an Re (heptoseless) chemotype (Table 3).
This chemotype contains the least amount of LPS (only lipid A and
2-keto-3-deoxyoctonic acid). None of the LPS mutants was sensitive to
pediocin PA-1. The Rc to Re chemotypes had different levels of
sensitivity to nisin, and inhibition of Salmonella mutants increased with increasing concentrations. This was not the case with
increasing concentrations of brochocin-C above 800 AU/ml.
Activity against spheroplasts.
Addition of brochocin-C and
nisin to spheroplasts of Typhimurium LT2 and its Re-type mutant SL3600
resulted in a decrease in absorbance at 600 nm (Fig.
1); however, when pediocin PA-1 was
added, even at 3,200 AU/ml, no decrease in absorbance at 600 nm was
observed during 170 min of exposure (data not shown). LT2 spheroplasts
were more sensitive to brochocin-C than nisin, but the rate of action
of brochocin-C against SL3600 spheroplasts was lower than that of
nisin. The decrease in absorbance with brochocin-C and nisin treatment
of LT2 spheroplasts was less than that observed in SL3600 spheroplasts.
Brochocin-C and nisin only caused decreases in absorbance at 600 nm of
0.2 and 0.12, respectively. Furthermore, the reaction between the
bacteriocins and spheroplasts was slow, requiring about 50 min for
absorbance of nisin-treated LT2 spheroplasts to decrease 0.1 U, while
absorbance of brochocin-treated LT2 spheroplasts decreased throughout
the time of the experiment. During treatment for 170 min, there were
3.2- and 2.8-log reductions in the viability of SL3600 spheroplasts
treated with brochocin-C and nisin, respectively, compared with 2- and
1.4-log reductions of LT2 spheroplasts.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of brochocin-C and nisin (800 AU/ml, final
concentration) on absorbance of spheroplasts of Typhimurium LT2 (A) and
its LPS mutant SL3600 (B). Lysis was monitored at 600 nm. Symbols: ,
spheroplasts plus water; , spheroplasts plus nisin; ,
spheroplasts plus brochocin-C. Data are representative of three
determinations.
|
|
ATP hydrolysis during treatment with bacteriocins.
Absorbance
at 260 nm of spheroplasts treated with brochocin-C and nisin increased,
but not with pediocin PA-1 (data not shown). Total and extracellular
ATP contents were determined on LT2 and SL3600 cells and spheroplasts
treated with bacteriocins. The protonophore CCCP, which dissipates
proton motive force, was used as a control. When spheroplasts were
energized with 0.5% glucose, the total ATP concentration increased,
reaching a maximum after 30 min, after which the bacteriocins were
added (800 AU/ml). ATP hydrolysis was detected immediately after
addition of brochocin-C or nisin to spheroplasts (Fig.
2). The ATP content of spheroplasts
treated with pediocin PA-1 was similar to that of the negative control (data not shown). The total ATP dropped by more than 70% in 1 min for
spheroplasts of LT2 treated with brochocin-C or nisin. Thereafter, only
minor ATP hydrolysis occurred. Total ATP dropped to less than 10%
immediately after addition of brochocin-C, nisin, or CCCP to SL3600
spheroplasts. External ATP was not detected in spheroplasts treated
with brochocin-C (data not shown), while external ATP was 40 to 50% of
total ATP in nisin-treated spheroplasts (Fig. 2). Similarly, the ATP
concentration increased when LT2 and SL3600 cells were energized with
glucose (Fig. 3). Upon addition of
brochocin-C or nisin, the total ATP dropped within 1 min to 74 or 66%
in LT2 cells and to 65 or 54% in SL3600 cells, respectively. Cells of
LT2 and SL3600 treated with CCCP retained about 45% of their ATP and
maintained these levels during the 70-min treatment period. LT2 cells
treated with brochocin-C and nisin gradually replaced their ATP, and
recovery was at 86% of ATP after 70 min of incubation in the presence
of either bacteriocin. The external ATP of SL3600 cells treated with
nisin was 30% of the total ATP (Fig. 3B), but external ATP was not
detected in LT2 cells treated with nisin or in LT2 and SL3600 cells
treated with brochocin-C (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of brochocin-C and nisin on total ATP levels in
spheroplasts of Typhimurium LT2 (A) and its LPS mutant SL3600 (B) after
30 min of energizing with 0.5% glucose. The vertical arrow represents
the time at which bacteriocins were added. The ATP levels are a
percentage of the total ATP at 30 min. Symbols: , water; ,
brochocin-C; , nisin; *, CCCP; , nisin-induced ATP leakage. Data
are means of three determinations.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of brochocin-C and nisin on total levels of ATP
in cells of Typhimurium LT2 (A) and its LPS mutant SL3600 (B) after 30 min of energizing with 0.5% glucose. The vertical arrow represents the
time at which bacteriocins were added. ATP levels are a percentage of
the total ATP at 30 min. Symbols: , water; , brochocin-C; ,
nisin; *, CCCP. In Fig. 3B, nisin-induced ATP leakage is also shown
( ). Data are means of three determinations.
|
|
 |
DISCUSSION |
Stevens et al. (24) showed that, in the presence of
EDTA, nisin was active against cells of Salmonella and
E. coli. We confirmed this with the same protocol by using
two of the same target organisms, except that under our experimental
conditions there was a smaller reduction in viable count. There was a
comparable loss of viability of gram-negative bacteria when they were
treated with brochocin-C and EDTA. Previously, we observed that
brochocin-C might be toxic to E. coli when we used the
general secretion pathway to produce this bacteriocin in this host
(15). Access of bacteriocin to the cytoplasmic membrane is
the key to activity of nisin and brochocin-C against gram-negative
bacteria. Even though LPS mutants have the same chemotype, they do not
necessarily have identical surface structures (26). This
might explain why only Re strains SL3600 and SL1102 and not SA1377 are
sensitive to brochocin-C. The ability of nisin and brochocin-C to
penetrate the outer membrane of gram-negative cells most probably
differs. The outer membrane can be made permeable to lysozyme by the
use of a divalent ion chelator, such as EDTA, which loosens the
structure of LPS. This leads to the disruption but not the complete
removal of the outer membrane. Spheroplasts made with EDTA and lysozyme
treatment contain some adherent outer membrane and entrapped murein
(16).
Assuming that brochocin-C forms pores in the cytoplasmic membrane like
other bacteriocins, pores formed by brochocin-C are smaller than those
formed by nisin. ATP was released from SL3600 cells and spheroplasts,
as well as LT2 spheroplasts treated with nisin, but not as a result of
treatment with brochocin-C. Addition of nisin Z to Listeria
monocytogenes resulted in hydrolysis and partial efflux of
cellular ATP (3). Nisin forms transient multistate pores
with a diameter ranging from 0.2 to 1.2 nm in black lipid membranes
(1). This supports our observation that lysis of intracellular ATP by nisin is accompanied by substantial ATP leakage in
spheroplasts and SL3600 cells. ATP leakage was not detected in LT2
cells, and intracellular decrease of ATP was less dramatic. Furthermore, cells of LT2 increase their rate of ATP production after
treatment with nisin and brochocin-C (Fig. 3A). This might explain why
brochocin-C and nisin do not affect viability of LT2. Spheroplasts of
LT2 are more resistant to brochocin-C and nisin treatment than SL3600
spheroplasts (Fig. 2A), indicating that intact LPS provides protection
to the cytoplasmic membrane.
Addition of brochocin-C to energized cells and spheroplasts resulted in
a decrease in the intracellular ATP concentration, but no external ATP
was detected. A similar observation was made with lactacin F on
Enterococcus faecalis (2) and colicin A on
E. coli (9). These authors proposed that ATP
hydrolysis was caused by an efflux of inorganic phosphate resulting in
a shift of the ATP hydrolysis equilibrium and/or the accelerated consumption of ATP to regenerate the decreased proton motive force. Dissipation of the proton motive force by CCCP reduced the
intracellular ATP pool, indicating an enhanced use of ATP to regenerate
the proton motive force. The effect of CCCP on the intracellular ATP pool was comparable in LT2 and SL3600 cells.
Two-peptide bacteriocins, such as lactacin F (2) and
thermophilin 13 (14), form poration complexes in the
cytoplasmic membrane. Thermophilin 13 is very similar in chemical
structure to brochocin-C (15) and does not depend on
membrane components from sensitive strains for its activity because it
is active on liposomes (14). The results in this study might
indicate that brochocin-C does not require a specific receptor for the
bacteriocin to be active. This would explain why brochocin-C has a
broad activity spectrum against gram-positive bacteria and it affects
gram-negative bacteria when the outer membrane is impaired.
 |
ACKNOWLEDGMENTS |
This study was supported by a grant from the Natural Sciences and
Engineering Research Council of Canada.
We thank K. E. Sanderson (Department of Biology, University of
Calgary, Alberta, Canada) for providing the Salmonella LPS mutants and L. Steele for editing the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Agricultural, Food and Nutritional Science, University of Alberta,
Edmonton, Alberta T6G 2P5, Canada. Phone: (780) 492-2386. Fax: (780)
492-8916. E-mail: mstiles{at}afns.ualberta.ca.
 |
REFERENCES |
| 1.
|
Abee, T.
1995.
Pore-forming bacteriocins of gram-positive bacteria and self-protection mechanisms of producer organisms.
FEMS Microbiol. Lett.
129:1-10[Medline].
|
| 2.
|
Abee, T.,
T. R. Klaenhammer, and L. Letellier.
1994.
Kinetic studies of the action of lactacin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane.
Appl. Environ. Microbiol.
60:1006-1013[Abstract/Free Full Text].
|
| 3.
|
Abee, T.,
F. M. Rombouts,
J. Hugenholtz,
G. Guihard, and L. Letellier.
1994.
Mode of action of nisin Z against L. monocytogenes Scott A grown at high and low temperatures.
Appl. Environ. Microbiol.
60:1962-1968[Abstract/Free Full Text].
|
| 4.
|
Ahn, C., and M. E. Stiles.
1990.
Plasmid-associated bacteriocin produced by a strain of Carnobacterium piscicola from meat.
Appl. Environ. Microbiol.
56:2503-2510[Abstract/Free Full Text].
|
| 5.
|
Boziaris, I. S.,
L. Humpheson, and M. R. Adams.
1998.
Effect of nisin on heat injury and inactivation of Salmonella enteritidis PT4.
Int. J. Food Microbiol.
43:7-13[Medline].
|
| 6.
|
Delves-Broughton, J.
1990.
Nisin and its uses as a food preservative.
Food Technol.
44:100, 102, 104, 106, 108, 111, 112, 117.
|
| 7.
|
García Garcerá, M. J.,
M. G. L. Elferink,
A. J. M. Driessen, and W. N. Konings.
1993.
In vitro pore-forming activity of the lantibiotic nisin. Role of protonmotive force and lipid composition.
Eur. J. Biochem.
212:417-422[Medline].
|
| 8.
|
Gonzalez, C. F., and B. S. Kunka.
1987.
Plasmid-associated bacteriocin production and sucrose fermentation in Pediococcus acidilactici.
Appl. Environ. Microbiol.
53:2534-2538[Abstract/Free Full Text].
|
| 9.
|
Guihard, G.,
H. Bénédetti,
M. Besnard, and L. Letellier.
1993.
Phosphate efflux through the channels formed by colicins and phage T5 in Escherichia coli cells is responsible for the fall in cytoplasmic ATP.
J. Biol. Chem.
268:17775-17780[Abstract/Free Full Text].
|
| 10.
|
Henderson, J. T.,
A. L. Chopko, and P. D. van Wassenaar.
1992.
Purification and primary structure of pediocin PA-1 produced by Pediococcus acidilactici PAC-1.0.
Arch. Biochem. Biophys.
295:5-12[Medline].
|
| 11.
|
Hurst, A.
1972.
Interactions of food starter cultures and food-borne pathogens: the antagonism between Streptococcus lactis and sporeforming microbes.
J. Milk Food Technol.
35:418-423.
|
| 12.
|
Kalchayanand, N.,
M. B. Hanlin, and B. Ray.
1992.
Sublethal injury makes gram-negative and resistant gram-positive bacteria sensitive to the bacteriocins, pediocin AcH and nisin.
Lett. Appl. Microbiol.
15:239-243.
|
| 13.
|
Kordel, M.,
F. Schüller, and H.-G. Sahl.
1989.
Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes.
FEBS Lett.
244:99-102[Medline].
|
| 14.
|
Marciset, O.,
M. C. Jeronimus-Stratingh,
B. Mollet, and B. Poolman.
1997.
Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor.
J. Biol. Chem.
272:14277-14284[Abstract/Free Full Text].
|
| 15.
|
McCormick, J. K.,
A. Poon,
M. Sailer,
Y. Gao,
K. L. Roy,
L. M. McMullen,
J. C. Vederas,
M. E. Stiles, and M. J. van Belkum.
1998.
Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754.
Appl. Environ. Microbiol.
64:4757-4766[Abstract/Free Full Text].
|
| 16.
|
Neidhardt, F. C.,
J. L. Ingraham, and M. Schaechter.
1990.
Physiology of the bacterial cell: a molecular approach.
Sinauer Associates, Inc., Publishers, Sunderland, Mass.
|
| 17.
|
Osborn, M. J.,
J. E. Gander,
E. Parisi, and J. Carson.
1972.
Mechanism of assembly of the outer membrane of Salmonella typhimurium. Isolation and characterization of cytoplasmic and outer membrane.
J. Biol. Chem.
247:3962-3972[Abstract/Free Full Text].
|
| 18.
|
Rothfield, L.,
M. J. Osborn, and B. L. Horecker.
1964.
Biosynthesis of bacterial lipopolysaccharide. II. Incorporation of glucose and galactose catalyzed by particulate and soluble enzymes in Salmonella.
J. Biol. Chem.
239:2788-2795[Free Full Text].
|
| 19.
|
Ruhr, E., and H.-G. Sahl.
1985.
Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles.
Antimicrob. Agents Chemother.
27:841-845[Abstract/Free Full Text].
|
| 20.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 21.
|
Sanderson, K. E.,
T. MacAlister,
J. W. Costerton, and K. J. Cheng.
1974.
Permeability of lipopolysaccharide-deficient (rough) mutants of Salmonella typhimurium to antibiotics, lysozyme, and other agents.
Can. J. Microbiol.
20:1135-1145[Medline].
|
| 22.
|
Siragusa, G. R., and C. N. Cutter.
1993.
Brochocin-C, a new bacteriocin produced by Brochothrix campestris.
Appl. Environ. Microbiol.
59:2326-2328[Abstract/Free Full Text].
|
| 23.
|
Stevens, K. A.,
N. A. Klapes,
B. W. Sheldon, and T. R. Klaenhammer.
1992.
Antimicrobial action of nisin against Salmonella typhimurium lipopolysaccharide mutants.
Appl. Environ. Microbiol.
58:1786-1788[Abstract/Free Full Text].
|
| 24.
|
Stevens, K. A.,
B. W. Sheldon,
N. A. Klapes, and T. R. Klaenhammer.
1991.
Nisin treatment for inactivation of Salmonella species and other gram-negative bacteria.
Appl. Environ. Microbiol.
57:3613-3615[Abstract/Free Full Text].
|
| 25.
|
van Belkum, M. J.,
J. Kok,
G. Venema,
H. Holo,
I. F. Nes,
W. N. Konings, and T. Abee.
1991.
The bacteriocin lactococcin A specifically increases permeability of lactococcal cytoplasmic membranes in a voltage-independent, protein-mediated manner.
J. Bacteriol.
173:7934-7941[Abstract/Free Full Text].
|
| 26.
|
Weinbaum, G.,
S. Kadis, and S. J. Ajl.
1971.
Microbial toxins, vol. IV. Bacterial endotoxins.
Academic Press, Inc., New York, N.Y.
|
Applied and Environmental Microbiology, October 1999, p. 4329-4333, Vol. 65, No. 10
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Garneau, S., Ference, C. A., van Belkum, M. J., Stiles, M. E., Vederas, J. C.
(2003). Purification and Characterization of Brochocin A and Brochocin B(10-43), a Functional Fragment Generated by Heterologous Expression in Carnobacterium piscicola. Appl. Environ. Microbiol.
69: 1352-1358
[Abstract]
[Full Text]
-
Gänzle, M. G., Höltzel, A., Walter, J., Jung, G., Hammes, W. P.
(2000). Characterization of Reutericyclin Produced by Lactobacillus reuteri LTH2584. Appl. Environ. Microbiol.
66: 4325-4333
[Abstract]
[Full Text]